Finance

Lists
LABS:TSE
Medipharm Labs Corp
0,070 CA$
0,00%
(0,00) 1D
13 қаз., 16:00:00 GMT-4  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for LABS...
Open
0,07 CA$
High
0,07 CA$
Low
0,06 CA$
Mkt. cap
29,90 млн
Avg. vol.
97,26 мың
Volume
207,42 м.
52-wk high
0,10 CA$
52-wk low
0,06 CA$
EPS
-0,01 CA$
Beta
0,43
Shares outstanding
427,18 млн
No. of employees
127
Open
0,07 CA$
High
0,07 CA$
Low
0,06 CA$
Mkt. cap
29,90 млн
Avg. vol.
97,26 мың
Volume
207,42 м.
52-wk high
0,10 CA$
52-wk low
0,06 CA$
EPS
-0,01 CA$
Beta
0,43
Shares outstanding
427,18 млн
No. of employees
127
News stories
From web sources and news partners
About Medipharm Labs Corp
CEO-
Employees127
Founded2015
HeadquartersBarrie, Онтарио, Канада
SectorPharmaceutical industry
Last report
2026 ж. 13 там.
Fiscal period
Q2 2026
- / -
Revenue / Est. (CAD)
9,98 млн / 8,93 млн
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
2025 ж. қыр.
2025 ж. жел.
2026 ж. нау.
2026 ж. мау.
Revenue
11,45 млн
11,06 млн
8,96 млн
9,98 млн
Cost of goods sold
8,90 млн
7,26 млн
5,65 млн
5,56 млн
Cost of revenue
8,90 млн
7,26 млн
5,65 млн
5,56 млн
Research and development expenses
47,00 мың
52,00 мың
24,00 мың
83,00 мың
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,50 млн
4,40 млн
4,28 млн
3,93 млн
Operating expense
4,74 млн
4,77 млн
4,30 млн
4,35 млн
Total operating expenses
13,64 млн
12,03 млн
9,96 млн
9,90 млн
Operating income
-2,19 млн
-967,00 м.
-994,00 м.
82,00 мың
Other non operating income
-
-
-
-
EBT including unusual items
-2,14 млн
-1,97 млн
-867,00 м.
4,00 мың
EBT excluding unusual items
-2,14 млн
-965,00 м.
-867,00 м.
120,00 м.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
189,00 м.
358,00 м.
-2,00 мың
-110,00 м.
Net income
-2,14 млн
-1,97 млн
-867,00 м.
4,00 мың
Net profit margin
-18,71%
-17,79%
-9,67%
0,04%
Earnings per share
-
-
-
-
Interest and investment income
62,00 мың
58,00 мың
60,00 мың
50,00 мың
Interest expense
-16,00 мың
-19,00 мың
-15,00 мың
-12,00 мың
Net interest expenses
46,00 мың
39,00 мың
45,00 мың
38,00 мың
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,78 млн
-580,00 м.
-621,00 м.
458,00 м.
Gain or loss from assets sale
181,00 м.
-
-
-
AI content may include mistakes. Learn more
Google қолданбалары